CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.390
-0.170 (-3.73%)
Apr 2, 2026, 2:00 PM EDT - Market open
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $949.02 million as of April 2, 2026. Its market cap has increased by 1,860.78% in one year.
Market Cap
949.02M
Enterprise Value
839.99M
1-Year Change
1,860.78%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $949.02M, an increase of 12,724.57%. That is a compound annual growth rate of 58.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 776.10M | 7.52% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 1.06B |
| uniQure | 1.06B |
| Xeris Biopharma Holdings | 1.04B |
| Inventiva | 1.01B |
| KalVista Pharmaceuticals | 1.01B |
| Inhibrx Biosciences | 979.40M |
| Compass Therapeutics | 977.88M |
| Aktis Oncology | 943.56M |